Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Puma Biotechnology, Inc. (PBYI) had Return on Tangible Equity of 12.38% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$54.48M |
|
$8.84M |
|
$12.17M |
|
$42.30M |
|
$44.90M |
|
$9.57M |
|
$-0.33M |
|
$9.24M |
|
$9.24M |
|
$8.84M |
|
$8.84M |
|
$8.84M |
|
$8.84M |
|
$9.57M |
|
$12.29M |
|
50.34M |
|
50.93M |
|
$0.18 |
|
$0.17 |
|
| Balance Sheet Financials | |
$143.58M |
|
$0.30M |
|
$59.28M |
|
$202.86M |
|
$82.73M |
|
-- |
|
$4.87M |
|
$87.59M |
|
$115.27M |
|
$71.44M |
|
$115.27M |
|
50.38M |
|
| Cash Flow Statement Financials | |
$27.38M |
|
$-9.21M |
|
$-33.87M |
|
$71.31M |
|
$55.62M |
|
$-15.69M |
|
$5.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.74 |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
77.65% |
|
17.57% |
|
17.57% |
|
-- |
|
16.97% |
|
16.23% |
|
$27.28M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
1.28 |
|
1.62 |
|
55.45 |
|
7.67% |
|
|
Return on Tangible Equity |
12.38% |
4.36% |
|
7.67% |
|
$2.29 |
|
$0.54 |
|
$0.54 |
|